SynthesisJournal of hospital medicine2026
Impact of remote biometric sensing on readmission risk and mortality after hospital discharge: Insights from a systematic review and meta-analysis.
Synthesis in Journal of hospital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From neuroinflammation to neural inference: computational psychiatry meets precision medicine.Schizophrenia (Heidelberg, Germany) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
introductionUnplanned hospital readmissions are associated with higher morbidity, mortality, and financial burden. This study evaluated the association between the use of remote biometric sensing devices (RBS) and all-cause readmission and mortality rates among adult patients discharged from the hospital.
methodsWe systematically searched MEDLINE, Embase, Scopus, and Global Health from inception to August 2023. Eligible studies assessed adult patients using RBS devices, defined as tools capable of automatically or manually measuring at least one biometric marker beyond physical activity, after hospital discharge. Studies required a comparison group and reported all-cause readmission rates. Risk ratios (RRs) with 95% confidence intervals (CIs) were summarized using random-effects models to account for variability. Subgroup analysis was conducted based on study design, follow-up period postdischarge, and index discharge diagnosis.
resultsOut of 9363 identified studies, 39 studies (23 randomized control trials, 14 cohort studies, and two nonrandomized trials) comprising 160,857 patients met the inclusion criteria. RBS use was associated with lower risk of all-cause readmission (RR = 0.75; 95% CI: 0.67-0.84, I
conclusionAmong patients recently discharged from the hospital, RBS use is associated with improved short-term outcomes. Future studies are needed to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.